Uemura K, Shintani-Ishida K, Saka K, Nakajima M, Ikegaya H, Kikuchi Y, Yoshida KI (2008) Biochemical blood markers and sampling sites in forensic autopsy. J. Forensic Leg Med 15(5):312–317
Madea B. Musshoff F (2007) Postmortem biochemistry. Forensic Sci Int 165(2–3):165–171
Arroyo A, Rosel P, Marron T (2005) Cerebrospinal fluid: postmortem biochemical study. J Clin Forensic Med 12(3):153–156
Article CAS PubMed Google Scholar
Chen JH, Inamori-Kawamoto O, Michiue T, Ikeda S, Ishikawa T, Maeda H (2015) Cardiac biomarkers in blood, and pericardial and cerebrospinal fluids of forensic autopsy cases: a reassessment with special regard to postmortem interval. Leg. Med 17(5):343–350
Maeda H, Ishikawa T, Michiue T (2011) Forensic biochemistry for functional investigation of death: concept and practical application. Leg. Med 13(2):55–67
Maeda H, Zhu BL, Ishikawa T, Quan L, Michiue T (2009) Significance of postmortem biochemistry in determining the cause of death. Leg. Med 11:46–49
Luna A, Villanueva E, Castellano MA, Jimenez G (1982) The determination of CK, LDH and its isoenzymes in pericardial fluid and its application to the post-mortem diagnosis of myocardial infarction. Forensic Sci Int 19(1):85–91
Luna A (2009) Is postmortem biochemistry really useful? Why is it not widely used in forensic pathology? Leg Med 11:27–30
Belsey SL, Flanagan RJ (2016) Postmortem biochemistry: current applications. J Forensic Leg Med 41:49–57
Michaud K, Augsburger M, Donzé N, Sabatasso S, Faouzi M, Bollmann M, Mangin P (2008) Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function. Int J Legal Med 122(5):415–420
Cina SJ, Chan DW, Boitnott JK, Hruban RH, Smialek JE (1998) Serum concentrations of cardiac troponin I in sudden death: a pilot study. Am J Forensic Med Pathol 19(4):324–328
Article CAS PubMed Google Scholar
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (2008) Harrison’s principles of internal medicine, 17th edn. McGraw-Hill, New York
Macdonald G, Medicine Harrison’sI, Fauci -byAS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J (2008) Intern Med J 38(12):932–932
Sureka B, Bansal K, Arora A (2015) Pulmonary edema–cardiogenic or noncardiogenic? J Family Med Prim Care 4(2):290
Arrigo M, Parenica J, Ganovska E, Pavlusova M, Mebazaa A (2019) Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary síndrome. IJC Heart Vasculature 22:174–176
Article PubMed PubMed Central Google Scholar
Choi JJ, McCarthy MW (2018) The prognostic value of mid-regional pro-adrenomedullin in the evaluation of acute dyspnea. Expert Rev Mol Diagn 18(2):147–153 Epub 2018 Jan 19. PMID: 29319365
Article CAS PubMed Google Scholar
Wei Y, Tanaka M, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Cui N, Kakihara S, Zhao Y, Aruga K, Sanjo H, Shindo T (2021) Adrenomedullin ameliorates pulmonary fibrosis by regulating TGF-ß-Smads signaling and myofibroblast differentiation. Endocrinology 162(8):bqab090. https://doi.org/10.1210/endocr/bqab090. PMID: 33955458
Holmes D, Campbell M, Harbinson M, Bell D (2013) Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP. Curr Protein Pept Sci 14(4):294–329. https://doi.org/10.2174/13892037113149990049. PMID: 23745696
Williams L, Brown T, Lee H (2021) Cortisol levels in forensic medicine: diagnostic applications. Forensic Sci J 68(2):145–159
Brown S, Green M (2018) Post-mortem cortisol stability. J Forensic Sci 63(4):786–793
Lang LM, Linnet K (2013) Postmortem urinary cortisol levels in relation to the cause of death. J Forensics Res 4(3):1–4
Yoshizawa T, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Iesato Y, Tanaka M (2013) Novel regulation of cardiac metabolism and homeostasis by the adrenomedullin-receptor activity-modifying protein 2 system. Hypertension 61(2):341–351
Article CAS PubMed Google Scholar
Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJ (2004) The clinical relevance of adrenomedullin: a promising profile? Pharmacol. Ther 103(3):179–201
Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A, Butler J (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21(2):163–171
Article CAS PubMed Google Scholar
Molvin J, Jujic A, Navarin S, Melander O, Zoccoli G, Hartmann O, Magnusson M (2019) Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting. Open Heart 6(2):e001048
Article PubMed PubMed Central Google Scholar
Ter Maaten JM, Kremer D, Demissei BG, Struck J, Bergmann A, Anker SD, Voors AA (2019) Bio-adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure. Eur J Heart Fail 21(6):732–743
Article CAS PubMed Google Scholar
Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Maggio G, Spanuth E (2017) Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis. Chest 152(2):312–320
Tolppanen H, Rivas-Lasarte M, Lassus J, Sans-Rosello J, Hartmann O, Lindholm M, Mebazaa A (2017) Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. Ann Intensive Care 7(1):1–10
Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuoka H (1994) Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94(5):2158–2161
Article CAS PubMed PubMed Central Google Scholar
Kremer D, Ter Maaten JM, Voors AA (2018) Bio-adrenomedullin as a potential quick, reliable, and objective marker of congestion in heart failure. Eur J Heart Fail 20(9):1363–1365
Tang WW (2010) Contemporary challenges in translating biomarker evidence into clinical practice. J Am Coll Cardiol 55:2077–2079
Article CAS PubMed Google Scholar
Beltowski J, Jamroz A (2004) Adrenomedullin–what do we know 10 years since its discovery? Pol J Pharmacol 56:5–27
Owji AA, Smith DM, Coppock HA, Morgan DG, Bhogal RANJEV, Ghatei MA, Bloom SR (1995) An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136(5):2127–2134
Article CAS PubMed Google Scholar
Wilke N, Janssen H, Fahrenhorst C, Hecker H, Manns MP, Brabant EG, Breitmeier D (2007) Postmortem determination of concentrations of stress hormones in various body fluids—is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time? Int J Legal Med 121(5):385–394
Article CAS PubMed Google Scholar
Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Quan L, Maeda H (2007) Postmortem serum catecholamine levels in relation to the cause of death. Forensic Sci Int 173(2–3):122–129
Article CAS PubMed Google Scholar
Lovallo WR, Farag NH, Vincent AS, Thomas TL, Wilson MF (2006) Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharmacol Biochem Behav 83(3):441–447
Article CAS PubMed PubMed Central Google Scholar
Whitworth JA, Williamson PM, Mangos G, Kelly JJ (2005) Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 1(4):291
Dugan AL, Malarkey WB, Schwemberger S, Jauch EC, Ogle CK, Horseman ND (2004) Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality. J Burn Care Rehabil 25(3):306–313
Article CAS PubMed Google Scholar
Desborough JP (2000) The stress response to trauma and surgery. Br J Anaesth 85(1):109–117
Comments (0)